Idibell

The Cursa Nocturna of l’Hospitalet raises 2.200 euros for IDIBELL

The funds will go to the Predicop project, which assesses the impact of changes in diet, exercise and lifestyle in improving the prognosis of recurrent breast cancer. 2,200 euros. This is the amount that the Cursa Nocturna Sport Ciutat de l’Hospitalet, held on Saturday April 16 on the occasion of the city Spring Festival, raised for the benefit of biomedical research at IDIBELL Predicop 2,108 catalan women hanges in lifestyle are crucial for improving the prognosis of cancer

The Cursa Nocturna of l’Hospitalet raises 2.200 euros for IDIBELL Read More »

Raquel Egea and Elisenda Batlle, new additions to IDIBELL

In recent days, our institution has added two new people in their management teams serving the research, transfer of knowledge generated by our researchers and, among others, clinical trials. On the one hand, Ms. Raquel Egea joins the Idibell with the position of head of the Office of Technology Transfer and Innovation. Egea is a

Raquel Egea and Elisenda Batlle, new additions to IDIBELL Read More »

Regulate lipids of neuronal membranes could be key in Alzheimer and Parkinson diseases

A study published in the journal Scientific Reports, of the Nature group, has demonstrated for the first time, using computational tools, that polyunsaturated lipids can alter the rate of binding of two types of receptors involved in some diseases of the nervous system. Researchers at UB Francisco Ciruela and Maricel Gómez-Soler (Faculty of Medicine and

Regulate lipids of neuronal membranes could be key in Alzheimer and Parkinson diseases Read More »

ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities

The Spanish Ministry of Economy and Competitiveness (MINECO) has granted a project to Bellvitge Biomedical Research Institute (IDIBELL) for the optimization, adaptation, improvement of facilities and acquisition of technological equipment at IDIBELL because of the forthcoming integration of the Center for Regenerative Medicine in Barcelona (CMRB) in these spaces. The project, which is funded by

ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities Read More »

ICFO and IDIBELL, together into new projects

joint conference ICFO-IDIBELL Detecting , Predicting and Fighting Resistance to antiangiogenic Therapies Non-invasive Monitoring of Local Hemodynamics to Characterize Suspicious Masses and to Predict Therapy Outcomes Applications to Biomedicine of Light and Nanotechnology Superresolution Techniques to Study Polarized Trafficking of Signaling Proteins in Photoreceptor Cells of the Retina Advanced Microscopy Techniques: Biomedical Imaging Applications at Nano, Micro and Macro Levels.

ICFO and IDIBELL, together into new projects Read More »

Identify a biochemical alteration responsible for the resistance of the most aggressive brain tumors

Researchers at the Institute of Neurosciences, UAB (INC) have identified the biochemical and molecular alterations leading to resistance to radiotherapy and chemotherapy in glioblastoma, the most aggressive brain tumor. The finding could allow, in the future, to design new, more effective therapies. Original article:

Identify a biochemical alteration responsible for the resistance of the most aggressive brain tumors Read More »

Xavier Bosch, IDIBELL Ombudsman

On October 14th, 2015, Dr. Francesc Xavier Bosch was presented and sanctioned by the Internal IDIBELL Scientific Committee as the Ombudsman of the institution. Dr. Bosch, Doctor of Medicine from the Autonomous University of Barcelona, has been responsible for the Cancer Epidemiology Research Program of the Catalan Institute of Oncology (ICO), head of the Infection

Xavier Bosch, IDIBELL Ombudsman Read More »

Scroll to Top